1. India Stocks

  2. •

    Financial Services

  3. •

    Investment - Banking & Investment Services
Biogen Pharmachem Industries L

Biogen Pharmachem Industries L

BIOGEN.BO
Biogen Pharmachem Industries LIN flagBombay Stock Exchange
0.30
INR
- -
- -
270.78MMarket Cap

Total Valuation

Biogen Pharmachem Industries L carries a market capitalization of 270.78M, placing it among publicly traded companies globally. Its enterprise value stands at 532.18M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap270.78M
Enterprise Value532.18M

Share Statistics

Biogen Pharmachem Industries L currently has 1.05B shares outstanding.

Shares Outstanding1.05B
Owned by Insiders (%)N/A
Owned by Institutions (%)N/A

Valuation Ratios

Biogen Pharmachem Industries L trades at a trailing price-to-earnings ratio of 56.13.

PE Ratio56.13
PS RatioN/A
PB Ratio0.60
P/TBV Ratio0.54
P/FCF RatioN/A
P/OCF RatioN/A

Enterprise Valuation

EV / SalesN/A
EV / EBITDA102.40
EV / EBIT102.40
EV / FCFN/A

Financial Position

Biogen Pharmachem Industries L maintains a current ratio of 2.27, meaning it holds 2.3x the short-term assets needed to cover near-term liabilities.

Current Ratio2.27
Quick Ratio2.27
Debt / EquityN/A
Debt / EBITDAN/A
Interest CoverageN/A

Financial Efficiency

Biogen Pharmachem Industries L posts a return on equity of 1.31 and a return on invested capital of 0.54.

Return on Equity (ROE)1.31
Return on Assets (ROA)1.00
Return on Invested Capital (ROIC)0.54
Return on Capital Employed (ROCE)1.31
Revenue Per EmployeeN/A
Employee CountN/A
Inventory TurnoverN/A

Stock Price Statistics

Biogen Pharmachem Industries L's stock has declined approximately -63.15809% over the past 52 weeks. The 50-day moving average sits at 0.36, while the 200-day moving average is 0.54.

Beta (5Y)N/A
52-Week Price Change-63.15809%
50-Day Moving Average0.36
200-Day Moving Average0.54
Average Volume (20 Days)N/A

Income Statement

EBITDA reached 5.20M, while operating income came in at 5.20M.

RevenueN/A
Gross Profit-2.83M
Operating Income5.20M
Pretax Income9.57M
Net Income9.57M
EBITDA5.20M
EBIT5.20M
Earnings Per Share (EPS)0.01

Balance Sheet

Total book value stands at 902.60M, with working capital of 2.73M providing operational flexibility.

Cash & Cash Equivalents4.87M
Total DebtN/A
Net Debt-3.22M
Equity (Book Value)902.60M
Book Value Per Share0.86
Working Capital2.73M

Stock Splits

Biogen Pharmachem Industries L's most recent stock split took place on May 15, 2026 with a 6:7 split ratio.

Last Split Date5/15/2026
Split Ratio6:7

Scores

Biogen Pharmachem Industries L posts an Altman Z-Score of 103.37, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.

Altman Z-Score103.37